Literature DB >> 16545694

Effect of heme and heme oxygenase-1 on vascular endothelial growth factor synthesis and angiogenic potency of human keratinocytes.

Agnieszka Jazwa1, Agnieszka Loboda, Slawomir Golda, Jaroslaw Cisowski, Magdalena Szelag, Anna Zagorska, Patrycja Sroczynska, Justyna Drukala, Alicja Jozkowicz, Jozef Dulak.   

Abstract

BACKGROUND: Skin injury leads to the release of heme, a potent prooxidant which is degraded by heme oxygenase-1 (HO-1) to carbon monoxide, iron, and biliverdin, subsequently reduced to bilirubin. Recently the involvement of HO-1 in angiogenesis has been shown; however, the role of heme and HO-1 in wound healing angiogenesis has not been yet investigated.
RESULTS: Treatment of HaCaT keratinocytes with hemin (heme chloride) induced HO-1 expression and activity. The effect of heme on vascular endothelial growth factor (VEGF) synthesis is variable: induction is significant after a short, 6 h treatment with heme, while longer stimulation may attenuate its production. The involvement of HO-1 in VEGF synthesis was confirmed by inhibition of VEGF expression by SnPPIX, a blocker of HO activity and by attenuation of HO-1 mRNA expression with specific siRNA. Importantly, induction of HO-1 by hemin was able to overcome the inhibitory effect of high glucose on VEGF synthesis. Moreover, HO-1 expression was also induced in keratinocytes cultured in hypoxia, with concomitant augmentation of VEGF production, which was further potentiated by hemin stimulation. Accordingly, conditioned media from keratinocytes overexpressing HO-1 enhanced endothelial cell proliferation and augmented formation of capillaries in angiogenic assay in vitro.
CONCLUSIONS: HO-1 is involved in hemin-induced VEGF expression in HaCaT and may play a role in hypoxic regulation of this protein. HO-1 overexpression may be beneficial in restoring the proper synthesis of VEGF disturbed in diabetic conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16545694      PMCID: PMC1414644          DOI: 10.1016/j.freeradbiomed.2005.11.016

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  47 in total

Review 1.  Wound healing: the role of growth factors.

Authors:  Anna T Grazul-Bilska; Mary Lynn Johnson; Jerzy J Bilski; Dale A Redmer; Lawrence P Reynolds; Ahmed Abdullah; Kay M Abdullah
Journal:  Drugs Today (Barc)       Date:  2003-10       Impact factor: 2.245

2.  Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin.

Authors:  Jun Fang; Tomohiro Sawa; Takaaki Akaike; Khaled Greish; Hiroshi Maeda
Journal:  Int J Cancer       Date:  2004-03       Impact factor: 7.396

3.  Gene therapy of endothelial nitric oxide synthase and manganese superoxide dismutase restores delayed wound healing in type 1 diabetic mice.

Authors:  Jian-Dong Luo; Ying-Ying Wang; Wei-Ling Fu; Jun Wu; Alex F Chen
Journal:  Circulation       Date:  2004-07-19       Impact factor: 29.690

4.  Opposite effects of prostaglandin-J2 on VEGF in normoxia and hypoxia: role of HIF-1.

Authors:  Alicja Józkowicz; Anneliese Nigisch; Joanna Wegrzyn; Guenter Weigel; Ihor Huk; Józef Dulak
Journal:  Biochem Biophys Res Commun       Date:  2004-01-30       Impact factor: 3.575

5.  Intercellular signalling within vascular cells under high D-glucose involves free radical-triggered tyrosine kinase activation.

Authors:  G Schaeffer; S Levak-Frank; M M Spitaler; E Fleischhacker; V E Esenabhalu; A H Wagner; M Hecker; W F Graier
Journal:  Diabetologia       Date:  2003-06-13       Impact factor: 10.122

6.  Ferritin: a cytoprotective antioxidant strategem of endothelium.

Authors:  G Balla; H S Jacob; J Balla; M Rosenberg; K Nath; F Apple; J W Eaton; G M Vercellotti
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

7.  Nitric oxide-dependent synthesis of vascular endothelial growth factor is impaired by high glucose.

Authors:  Józef Dulak; Katarzyna Tomala; Agnieszka Loboda; Alicja Józkowicz
Journal:  Life Sci       Date:  2004-10-08       Impact factor: 5.037

8.  Purification and properties of bovine spleen heme oxygenase. Amino acid composition and sites of action of inhibitors of heme oxidation.

Authors:  T Yoshinaga; S Sassa; A Kappas
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

Review 9.  Heme oxygenase-1: unleashing the protective properties of heme.

Authors:  Leo E Otterbein; Miguel P Soares; Kenichiro Yamashita; Fritz H Bach
Journal:  Trends Immunol       Date:  2003-08       Impact factor: 16.687

10.  Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.

Authors:  P Boukamp; R T Petrussevska; D Breitkreutz; J Hornung; A Markham; N E Fusenig
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

View more
  26 in total

1.  Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells.

Authors:  Agnieszka Loboda; Agnieszka Jazwa; Alicja Jozkowicz; Jerzy Dorosz; Jozsef Balla; Grietje Molema; Jozef Dulak
Journal:  Atherosclerosis       Date:  2006-04-18       Impact factor: 5.162

Review 2.  Molecular regulation of tumor angiogenesis and perfusion via redox signaling.

Authors:  Thomas W Miller; Jeff S Isenberg; David D Roberts
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

3.  Hypoxia-responsive microRNA-101 promotes angiogenesis via heme oxygenase-1/vascular endothelial growth factor axis by targeting cullin 3.

Authors:  Ji-Hee Kim; Kwang-Soon Lee; Dong-Keon Lee; Joohwan Kim; Su-Nam Kwak; Kwon-Soo Ha; Jongseon Choe; Moo-Ho Won; Byung-Ryul Cho; Dooil Jeoung; Hansoo Lee; Young-Guen Kwon; Young-Myeong Kim
Journal:  Antioxid Redox Signal       Date:  2014-07-29       Impact factor: 8.401

4.  Non-thermal plasma activates human keratinocytes by stimulation of antioxidant and phase II pathways.

Authors:  Anke Schmidt; Stephan Dietrich; Anna Steuer; Klaus-Dieter Weltmann; Thomas von Woedtke; Kai Masur; Kristian Wende
Journal:  J Biol Chem       Date:  2015-01-14       Impact factor: 5.157

5.  Overexpression of heme oxygenase-1 in murine melanoma: increased proliferation and viability of tumor cells, decreased survival of mice.

Authors:  Halina Was; Tomasz Cichon; Ryszard Smolarczyk; Dominika Rudnicka; Magdalena Stopa; Catherine Chevalier; Jean J Leger; Bozena Lackowska; Anna Grochot; Karolina Bojkowska; Anna Ratajska; Claudine Kieda; Stanislaw Szala; Jozef Dulak; Alicja Jozkowicz
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

6.  The role of vascular endothelial growth factor in fractional laser resurfacing with the carbon dioxide laser.

Authors:  Xia Jiang; Hongmei Ge; Chuanqing Zhou; Xinyu Chai; Qiu Shi Ren
Journal:  Lasers Med Sci       Date:  2011-10-01       Impact factor: 3.161

7.  Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs.

Authors:  Magdalena Kozakowska; Maciej Ciesla; Anna Stefanska; Klaudia Skrzypek; Halina Was; Agnieszka Jazwa; Anna Grochot-Przeczek; Jerzy Kotlinowski; Agnieszka Szymula; Aleksandra Bartelik; Milena Mazan; Oleksandr Yagensky; Urszula Florczyk; Krzysztof Lemke; Anna Zebzda; Grzegorz Dyduch; Witold Nowak; Krzysztof Szade; Jacek Stepniewski; Marcin Majka; Rafal Derlacz; Agnieszka Loboda; Jozef Dulak; Alicja Jozkowicz
Journal:  Antioxid Redox Signal       Date:  2011-10-19       Impact factor: 8.401

Review 8.  Empowering adult stem cells for myocardial regeneration.

Authors:  Sadia Mohsin; Sailay Siddiqi; Brett Collins; Mark A Sussman
Journal:  Circ Res       Date:  2011-12-09       Impact factor: 17.367

Review 9.  Heme oxygenase-1 in tumors: is it a false friend?

Authors:  Alicja Jozkowicz; Halina Was; Jozef Dulak
Journal:  Antioxid Redox Signal       Date:  2007-12       Impact factor: 8.401

10.  Possible relation of hemin-induced HO-1 expression to the upregulation of VEGF and BDNF mRNA levels in rat C6 glioma cells.

Authors:  Kyoji Morita; Mi-Sook Lee; Song Her
Journal:  J Mol Neurosci       Date:  2008-10-21       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.